Many Post-Covid Patients Are Experiencing New Medical Problems, Study Finds

Hundreds of thousands of Americans have sought medical care for post-Covid health problems that they had not been diagnosed with before becoming infected with the coronavirus, according to the largest study to date of long-term symptoms in Covid-19 patients. The study, tracking the health insurance records of nearly 2 million people in the United States who contracted the coronavirus last […]

Read more

Policies to review child abuse internally violate spirit of Colorado’s reporting law, ombudsman says

When the doctors and nurses at Children’s Hospital Colorado grew concerned that Kelly Turner might be medically abusing 7-year-old Olivia Gant before the girl died in 2017, they brought their concerns to the hospital’s internal child protection team. The child protection team at Children’s Hospital Colorado opted not to report the providers’ suspicions to the state’s Department of Human Services, […]

Read more

Outcry Forces UnitedHealthcare to Delay Plan to Deny Coverage for Some E.R. Visits

Just days after UnitedHealthcare announced that it would stop paying for emergency room hospital visits that it deemed nonurgent, the company faced mounting opposition and said on Thursday it would delay the policy shift until the pandemic had ended. Under the new policy, which was to go into effect next month, UnitedHealthcare, the giant insurer, had planned to scrutinize the […]

Read more

Moderna applies for U.S. authorization of its vaccine for use in adolescents.

Moderna requested an emergency authorization on Thursday from the Food and Drug Administration for use of its coronavirus vaccine in 12- to 17-year-olds. If authorized, as expected, the vaccine would offer a second option for protecting adolescents from the coronavirus, and hasten a return to normalcy for middle- and high-school students. The company has already filed for authorization with Health […]

Read more

AstraZeneca Vaccine Carries Slightly Higher Risk of Bleeding Disorders, Study Shows

People receiving the Covid vaccine made by Oxford-AstraZeneca had a slightly increased risk of a bleeding disorder, and possibly other rare blood problems, researchers reported on Wednesday. The findings, from a study of 2.53 million adults in Scotland who received their first doses of either the AstraZeneca vaccine or the one made by Pfizer-BioNTech, were published in the journal Nature […]

Read more

Looking to Tackle Prescription Overload

The last straw, for Leslie Hawkins, was her mother’s 93rd-birthday gathering in 2018. Her mother, Mary E. Harrison, had long contended with multiple health problems, including diabetes and the nerve pain it can cause; hypertension; anxiety; and some cognitive decline. She was prone to falling. Still, she had been a sociable, churchgoing nonagenarian until Ms. Hawkins, who cared for her […]

Read more

Alzheimer’s Drug Poses a Dilemma for the F.D.A.

The Food and Drug Administration is on the verge of announcing one of its most contentious decisions in years: the fate of an Alzheimer’s drug that could be the first treatment approved after nearly two decades of failed efforts to find ways to curb the debilitating disease. On Monday, the agency will rule on the drug, aducanumab, which aims to […]

Read more

Biden announces international COVID-19 vaccine sharing plan – The Denver Post

WASHINGTON — President Joe Biden announced Thursday the U.S. will donate 75% of its unused COVID-19 vaccines to the U.N.-backed COVAX global vaccine sharing program, acting as more Americans have been vaccinated and global inequities have become more glaring. Of the first tranche of 25 million doses, the White House said about 19 million will go to COVAX, with approximately […]

Read more

F.D.A. Approves Pricey Pill to Treat Vaginal Yeast Infections

The Food and Drug Administration on Tuesday approved a new drug to treat a vaginal yeast infection that is especially common in women who are pregnant, using birth control pills or taking antibiotics. The drug, Brexafemme (ibrexafungerp) made by SCYNEXIS, is a one-day oral treatment and the first of a new class of triterpenoid antifungal drugs. The company said the […]

Read more
1 2 3 68